导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 600511 | 国药股份 | 9.87% | 0.26% | 0.0257% |
| 301087 | 可孚医疗 | 9.21% | -0.94% | -0.0866% |
| 688108 | 赛诺医疗 | 9.21% | 5.52% | 0.5084% |
| 603883 | 老百姓 | 9.05% | 2.04% | 0.1846% |
| 605266 | 健之佳 | 8.76% | -0.50% | -0.0438% |
| 01099 | 国药控股 | 8.18% | -2.32% | -0.1898% |
| 000028 | 国药一致 | 5.05% | 0.92% | 0.0465% |
| 600129 | 太极集团 | 4.50% | 3.04% | 0.1368% |
| 600062 | 华润双鹤 | 4.35% | 2.01% | 0.0874% |
| 301188 | 力诺特玻 | 4.05% | 16.91% | 0.6849% |
| 重仓股合计:72.23%, 重仓股贡献增长率: 1.3541%, 总持股仓位:93.41%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-30 | 1.06% | 1.58% |
| 2024-04-29 | -0.44% | -0.24% |
| 2024-04-26 | 0.93% | 0.75% |
| 2024-04-25 | 1.50% | 1.55% |
| 2024-04-24 | 0.65% | 0.18% |
| 2024-04-23 | 0.03% | -0.30% |
| 2024-04-22 | 0.91% | 0.93% |
| 2024-04-19 | 0.05% | -0.03% |
| 基金名称 | 单位净值 | 增长率 |
| 恒生生物科技ETF | 0.4517 | 4.2951% |
| 华泰柏瑞新经济沪港深混合C | 0.9955 | 4.2362% |
| 嘉实前沿科技沪港深股票C | 1.4025 | 4.0889% |
| 港股医药 | 0.6579 | 3.9601% |
| 港科技50 | 0.7011 | 3.8733% |
| 港股通医药ETF | 0.7660 | 3.8703% |
| 科技HK | 0.6860 | 3.8652% |
| 香港科技 | 0.8177 | 3.8012% |
| 港股医药ETF | 0.5712 | 3.7540% |
| 港股科技ETF | 0.6479 | 3.7190% |
| 基金名称 | 单位净值 | 增长率 |
| 中庚港股通价值18个月封闭股票 | 0.9097 | 5.3265% |
| 嘉实前沿科技沪港深股票 | 1.4118 | 4.5511% |
| 嘉实前沿科技沪港深股票C | 1.4025 | 4.0889% |
| 广发港股通成长精选股票A | 0.5319 | 3.2166% |
| 广发港股通成长精选股票C | 0.5242 | 3.2166% |
| 汇丰港股通精选股票 | 0.6616 | 2.9782% |
| 易方达医药生物股票A | 0.6491 | 2.8087% |
| 易方达医药生物股票C | 0.6409 | 2.8087% |
| 创金合信港股通成长股票A | 0.4095 | 2.4536% |
| 创金合信港股通成长股票C | 0.4041 | 2.4536% |
